By Hassan Isilow
Doctors Without Borders (MSF) on Thursday criticized pharmaceutical corporations for their alleged delays and failure to develop appropriate formulations of HIV medicines for children.
“How long will children with HIV have to continue to suffer or die because of pure indifference?” the international humanitarian medical group said in a statement.
MSF says it has been forced to use older HIV drug treatments for children in their care which makes it difficult for them to stick to treatment, because of high rates of drug resistance in sub-Saharan Africa.
“Children need access to the best and most robust medicines possible given that they need to stay on HIV treatment for life,” said Jessica Burry, an HIV pharmacist at MSF’s access campaign.
The Switzerland-based medical charity has appealed to pharmaceutical corporations to start manufacturing and registering the much needed HIV drugs for infants so more young lives can be saved.
Ninety percent of all HIV infected children live in sub-Saharan Africa.
In 2017, AIDS-related illnesses killed 110,000 children worldwide.